Diabetes Clinical Trials: Emerging Trends And Pipeline Outlook

Table of Contents

Chapter 1. Research Methodology
                   1.1. Report Scope
                   1.2. List of Secondary Sources
                   1.3. List of Abbreviations
Chapter 2. Executive Summary
                   2.1. Diabetes Clinical Trials Landscape Overview
                   2.2. Market Dynamics
                   2.3. Prevalence Trends Analysis
                       2.3.1. Type 1 Diabetes Mellitus (T1DM)
                       2.3.2. Type 2 Diabetes Mellitus (T2DM)
                       2.3.3. Diabetes-Related Obesity and Weight Management
                       2.3.4. Cardiovascular Complications of Diabetes
                       2.3.5. Renal (Kidney) Complications
                       2.3.6. Diabetic Neuropathy
                       2.3.7. Diabetic Retinopathy and Ocular Complications
                       2.3.8. Gestational Diabetes
                       2.3.9. Others
                   2.4. R&D Investment & Funding Analysis
                   2.5. Industry Ecosystem Analysis
                   2.6. Regulatory Framework
                   2.7. List of Top 50 Active Trials by Phase, Sponsor, and Indication
                   2.8. Emerging Clinical Trial Model Analysis
Chapter 3. Global Diabetes Clinical Trials, by Phase
                   3.1. Phase I
                   3.2. Phase II
                   3.3. Phase III
                   3.4. Phase IV
Chapter 4. Global Diabetes Clinical Trials, by Study Design
                   4.1. Interventional Trials
                   4.2. Observational Studies
                   4.3. Expanded Access
Chapter 5. Global Diabetes Clinical Trials, by Key Indications
                   5.1. Type 1 Diabetes Mellitus (T1DM)
                   5.2. Type 2 Diabetes Mellitus (T2DM)
                   5.3. Diabetes-Related Obesity and Weight Management
                   5.4. Cardiovascular Complications of Diabetes
                   5.5. Renal (Kidney) Complications
                   5.6. Diabetic Neuropathy
                   5.7. Diabetic Retinopathy and Ocular Complications
                   5.8. Gestational Diabetes
                   5.9. Others
Chapter 6. Global Diabetes Clinical Trials, by Region
                   6.1. North America
                   6.2. Europe
                   6.3. Asia Pacific
                   6.4. Latin America
                   6.5. Middle East & Africa